On April 11, 2024, a “Kazakhstan-Finland” roundtable was held, organized by the Ministry of Ecology and Natural Resources of the Republic of Kazakhstan and the national company Kazakh Invest.
At the event, Yergali Abdurayimov, General Director of JSC National Holding QazBioPharm, presented the main areas of activity of the Holding and its subsidiary organizations.
These included medical and veterinary drugs and vaccines produced by the Holding, as well as its overall capabilities.
The purpose of the event was to familiarize Finnish representatives with Kazakhstan’s trade and investment potential and to expand bilateral cooperation.
It is worth noting that on December 4, 2023, a Partnership and Supply Agreement was signed in Helsinki (Finland) between JSC National Holding QazBioPharm and the leading Finnish pharmaceutical company Orion Corporation.
